A robust Bayesian two-sample test for detecting intervals of differential gene expression in microarray time series.

Understanding the regulatory mechanisms that are responsible for an organism's response to environmental change is an important issue in molecular biology. A first and important step towards this goal is to detect genes whose expression levels are affected by altered external conditions. A range of methods to test for differential gene expression, both in static as well as in time-course experiments, have been proposed. While these tests answer the question whether a gene is differentially expressed, they do not explicitly address the question when a gene is differentially expressed, although this information may provide insights into the course and causal structure of regulatory programs. In this article, we propose a two-sample test for identifying intervals of differential gene expression in microarray time series. Our approach is based on Gaussian process regression, can deal with arbitrary numbers of replicates, and is robust with respect to outliers. We apply our algorithm to study the response of Arabidopsis thaliana genes to an infection by a fungal pathogen using a microarray time series dataset covering 30,336 gene probes at 24 observed time points. In classification experiments, our test compares favorably with existing methods and provides additional insights into time-dependent differential expression.

Effects of blood extraction on horseshoe crabs (Limulus polyphemus)

Horseshoe crabs (Limulus polyphemus) are caught by commercial fishermen for use as bait in eel and whelk fisheries (Berkson and Shuster, 1999)—fisheries with an annual economic value of $13 to $17 million (Manion et al.1). Horse-shoe crabs are ecologically important, as well (Walls et al., 2002). Migratory shorebirds rely on horseshoe crab eggs for food as they journey from South American wintering grounds to Arctic breeding grounds (Clark, 1996). Horse-shoe crabs are also essential for public health (Berkson and Shuster, 1999). Biomedical companies bleed horse-shoe crabs to extract a chemical used to detect the presence of endotoxins pathogenic to humans in injectable and implantable medical devices (Novitsky, 1984; Mikkelsen, 1988). Bled horseshoe crabs are returned to the wild, subject to the possibility of postbleeding mortality. Recent concerns of overharvesting have led to conflicts among commercial fishermen, environmentalists acting on behalf of the shorebirds, and biomedical companies (Berkson and Shuster, 1999; Walls et al., 2002).